July 21, 2021

Top Biotech Penny Stocks to Watch in July 2021

It is a fast and competitive world! Some people are leaving others behind, whilst time is leaving everyone behind. You should always try and keep up with time, however, keeping up with the vast aggregate of penny stocks in the market can be extremely tricky.

Biotech companies are companies that research, develop, try, and test products proposed towards medical or agricultural applications. Whereas, penny stocks are stocks of small and developing companies who lack liquidity. These stocks are traded under $5 dollars per share.

The scope of success of companies that offer trading Biotech Penny Stocks is tremendous and immense, and likewise, the possibility of extremely inherent risks is inevitable. However, to save you the time and trouble of observing and inspecting an unending list of penny stock, we have curated a list of equities to monitor in your watchlist:

Disclaimer: Penny stocks are highly volatile. Remember to do your own research before investing in any of them; only invest to the limit where you can tolerate a loss.

Acasti Pharma Inc. (ACST)

Acasti is a biopharmaceutical innovator that is developing and commercializing prescription drugs using OM3 fatty acids, acquired from krill oil. They are aiming towards treating and eliminating cardiometabolic diseases. Recently, they have also announced entering into a definitive agreement to acquire Grace Therapeutic, Inc., an emerging biopharmaceutical company that is aiming towards nursing rare and orphan diseases.

Clearly, ACST has a lot going on, and we definitely recommend adding it to your penny stock watchlist.

Cellect Biotechnology Ltd.

Bringing about a revolution in the world of medicine, Cellect Biotechnology is producing ‘Regenerative medicine’ that is replacing damaged tissues and organs, rather than fixing them with drugs, chemicals, or radiation. Stem cells are the building blocks of our body, but building these cells is a complex, time-consuming, and expensive procedure. Their cultivation is incredibly strenuous, and Cellect has completely changed that. It is enabling feasible and fast stem cell therapy using their regenerative medicine.

In March 2021, Cellect filed a registered statement with a proposed strategic merger with privately-held Quoin Pharmaceuticals. It stated that with Quoins clinical programs and with its secured investments of around $25.5 million, it can and will benefit the shareholders, and stride forward greatly!

The price of this share soared about 57% after this announcement. Keep a close watch on this one!

Axim Biotechnologies, Inc. (OTCMKTS: AXIM):

Axim Biotechnologies is a vertically integrated research and development company concentrating on changing the diagnosis and treatment of oncology and Covid-19.

Axim had developed the first rapid (10 minutes) test that measures the concentration of neutralizing antibodies to Covid-19. Its clinical therapeutic research is aspiring to bring a novel oncology drug to the market. It is also developing various “point-of-care” diagnostic testing products designed for the early detection of cancer.

Thus, there are several big issues on their plate and big things that await. Though there is no recent news from the company, the stock is displaying a course of uptrends.

Xenetic Biosciences, Inc. (NASDAQ: XBIO)

Xenetic Biosciences, Inc. is another biopharmaceutical company aiming towards progressing XCART™, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is advancing cell-based therapeutics. Their patient- and tumor-specific approach is grabbing quite a number of eyeballs. The proprietary and patented technologies are creating life-changing therapies.

Albeit their stock has a relatively low float of about 8 million shares, it is trading higher than its average volume.

This is a must on your list of penny stock companies to watch!

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV)

It is pursuing the process of reconceptualizing spinal cord injuries and their treatments. They are aiming to promote neural regeneration after an injury by promoting cell survival and growth. It’s highly recommended pinning this one to your watchlist!

Over to you…

Indulging into penny stocks is only viable if you have a high tolerance for misdirects!

This unpredictable platform has a history of rewarding studied and carefully evaluated investments, so make sure to observe and examine before yielding.

There is risk, there is gain, but only if you use your brains!

About the author 

Peter Hatch

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}